Plasmatic and phenotypic effects with alirocumab, a PCSK9 inhibitor, in familial hypercholesterolemia treatment (FH)

Autor: Simonelli, Francesca, Miotti, Cristiano, Filice, Barbara Fausta, Gallo, Giovanna, Burocchi, Simone, Presta, Vivanne, Salerno, Gerardo, Abbolito, Sofia, Volpe, Massimo, De Biase, Luciano
Zdroj: In Atherosclerosis August 2017 263:e246-e247
Databáze: ScienceDirect